Does immunostaining effectively upstage colorectal cancer by identifying micrometastatic nodal disease?

International Journal of Colorectal Disease

Volumn 22, Issue 1, 2007, Pages 39-48

  Madbouly, Khaled M ^c   Senagore, Anthony J ^b   Mukerjee, Abir ^a,d   Delaney, Conor P ^a,d   Connor, Jason ^a   Fazio, Victor W ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

^b MEDICAL COLLEGE OF OHIO   (United States)

^c ALEXANDRIA UNIVERSITY   (Egypt)

^d UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

Author keywords

Cancer; Colorectal; Immunostaining; Micrometastasis

Indexed keywords

CYTOKERATIN; NUCLEOSIDE DIPHOSPHATE KINASE A; PROTEIN ANTIBODY; TUMOR MARKER; VASCULOTROPIN;

ADULT; AGED; ARTICLE; CANCER MORTALITY; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; COLORECTAL CANCER; CORRELATION ANALYSIS; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INCIDENCE; MAJOR CLINICAL STUDY; MEDIASTINUM METASTASIS; MICROMETASTASIS; PREDICTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; SENTINEL LYMPH NODE; TUMOR SUPPRESSOR GENE;

ADULT; AGED; AGED, 80 AND OVER; COLORECTAL NEOPLASMS; FOLLOW-UP STUDIES; HUMANS; IMMUNOHISTOCHEMISTRY; KERATINS; LYMPH NODES; LYMPHATIC METASTASIS; MIDDLE AGED; NEOPLASM STAGING; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES; TIME FACTORS; TUMOR MARKERS, BIOLOGICAL;

EID: 33751013321     PISSN: 01791958     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00384-006-0098-5     Document Type: Article

References (38)

1. Greenlee RT, Murray T, Bolden S et al (2000) Cancer statistics, 2000. CA Cancer J Clin 50 (1): 7-33
2. Jessup JM, McGinnis LS, Steele GD Jr et al (1996) The national cancer data base. Report on colon cancer. Cancer 78 (4): 918-926
3. Gelmann A, Desnoyers R, Cagir B et al (2000) Colorectal cancer staging and adjuvant chemotherapy. Expert Opin Pharmacother 1 (2): 737-755
4. Cohen AM, Tremiterra S, Candela F et al (1991) Prognosis of node-positive colon cancer. Cancer 67 (7): 1859-1861
5. Buie W, Rothenberger D (1993) Surveillance after curative resection of colorectal cancer: Individualizing follow-up. Gastrointest Endosc Clin N Am 3: 691-713
6. Adell G, Boeryd B, Franlund B et al (1996) Occurrence and prognostic importance of micrometastases in regional lymph nodes in Dukes' B colorectal carcinoma: An immunohistochemical study. Eur J Surg 162 (8): 637-642
7. Jeffers MD, O'Dowd GM, Mulcahy H et al (1994) The prognostic significance of immunohistochemically detected lymph node micrometastases in colorectal carcinoma. J Pathol 172 (2): 183-187
8. Greenson JK, Isenhart CE, Rice R et al (1994) Identification of occult micrometastases in pericolic lymph nodes of Duke's B colorectal cancer patients using monoclonal antibodies against cytokeratin and CC49. Correlation with long-term survival. Cancer 73 (3): 563-569
9. Yasuda K, Adachi Y, Shiraishi N et al (2001) Pattern of lymph node micrometastasis and prognosis of patients with colorectal cancer. Ann Surg Oncol 8 (4): 300-304
10. Gunn JMJ, Yun K, Wright PA (1996) Detection of micrometastases in colorectal cancer patients by K19 and K20 reverse-transcription polymerase chain reaction. Lab Invest 75 (4): 611-616
11. Liefers GJ, Cleton-Jansen AM, van de Velde CJ et al (1998) Micrometastases and survival in stage II colorectal cancer. N Engl J Med 339 (4): 223-228
12. Hayashi N, Ito I, Yanagisawa A et al (1995) Genetic diagnosis of lymph-node metastasis in colorectal cancer. Lancet 345 (8960): 1257-1259
13. Sasaki M WH, Jass JR, Ajioka Y, Kobayashi M, Matsuda K, Hatakeyama K (1997) Occult lymph node metastases detected by cytokeratin immunohistochemistry predict recurrence in "node-negative" colorectal cancer. J Gastroenterol 32 (6): 758-764
14. Cutait R, Alves V, Lopes L et al (1991) Restaging of colorectal cancer based on the identification of lymph node micrometastases through immunoperoxidase staining of CEA and cytokeratins. Dis Colon Rectum 34 (10): 917-920
15. Davidson B, Sams V, Styles J et al (1990) Detection of occult nodal metastases in patients with colorectal carcinoma. Cancer 65 (4): 967-970
16. Miyake Y, Yamamoto H, Fujiwara Y et al (2001) Extensive micrometastases to lymph nodes as a marker for rapid recurrence of colorectal cancer: A study of lymphatic mapping. Clin Cancer Res 7 (5): 1350-1357
17. Neumaier M, Gerhard M, Wagener C (1995) Diagnosis of micrometastases by the amplification of tissue-specific genes. Gene 159 (1): 43-47
18. Sloane J (1995) Molecules and micrometastases. Lancet 345: 1255-1256
19. Clarke G, Ryan E, O'Keane J et al (2000) The detection of cytokeratins in lymph nodes of Duke's B colorectal cancer subjects predicts a poor outcome. Eur J Gastroenterol Hepatol 12 (5): 549-525
20. Oberg A, Stenling R, Tavelin B et al (1998) Are lymph node micrometastases of any clinical significance in Duke's stages A and B colorectal cancer? Dis Colon Rectum 41 (10): 1244-1249
21. Gould VE, Bloom KJ, Franke WW et al (1995) Increased numbers of cytokeratin-positive interstitial reticulum cells (CIRC) in reactive, inflammatory and neoplastic lymphadenopathies: Hyperplasia or induced expression? Virchows Arch 425 (6): 617-629
22. Sarris M, Lee CS (2001) nm23 protein expression in colorectal carcinoma metastasis in regional lymph nodes and the liver. Eur J Surg Oncol 27 (2): 170-174
23. Dursun A, Akyurek N, Gunel N et al (2002) Prognostic implication of nm23-H1 expression in colorectal carcinomas. Pathology 34 (5): 427-432
24. Jen J, Kim H, Piantadosi S et al (1994) Allelic loss of chromosome 18q and prognosis in colorectal cancer. N Engl J Med 331 (4): 213-221
25. Bilchik AJ, Saha S, Wiese D et al (2001) Molecular staging of early colon cancer on the basis of sentinel node analysis: A multicenter phase II trial. J Clin Oncol 19 (4): 1128-1136
26. Merrie A, van Rij A, Phillips L et al (2001) Diagnostic use of the sentinel node in colon cancer. Dis Colon Rectum 44 (3): 410-417
27. Frank RE, Saclarides TJ, Leurgans S et al (1995) Tumor angiogenesis as a predictor of recurrence and survival in patients with node-negative colon cancer. Ann Surg 222 (6): 695-699
28. Tokunaga T, Oshika Y, Abe Y et al (1998) Vascular endothelial growth factor (VEGF) mRNA isoform expression pattern is correlated with liver metastasis and poor prognosis in colon cancer. Br J Cancer 77 (6): 998-1002
29. Bruns C, Liu W, Davis D et al (2000) Vascular endothelial growth factor is an in vivo survival factor for tumor endothelium in a murine model of colorectal carcinoma liver metastases. Cancer 89 (3): 488-499
30. Cascinu S, Staccioli M, Gasparini G et al (2000) Expression of vascular endothelial growth factor can predict event-free survival in stage II colon cancer. Clin Cancer Res 6 (7): 2803-2807
31. Morgan M, Koorey D, Painter D et al (2003) P53 and DCC immunohistochemistry in curative rectal cancer. Int J Colorectal Dis 18: 188-195
32. Fearon E, Cho K, Nigro J et al (1990) Identification of a chromosome 18q gene that is altered in colorectal cancers. Science 247: 49-56
33. Ookawa K, Sakamoto M, Hirohashi S et al (1993) Concordant p53 and DCC alterations and allelic losses on chromosomes 13q and 14q associated with liver metastases of colorectal carcinoma. Int J Cancer 53: 382-387
34. Shibata D, Reale M, Lavin P et al (1996) The DCC protein and prognosis in colorectal cancer. N Engl J Med 335: 1727-1732
35. Reymond M, Dworak O, Remke S et al (1998) DCC protein as a predictor of distant metastases after curative surgery for rectal cancer. Dis Colon Rectum 41: 775-760
36. Nordgard O, Aloysius TA, Todnem K et al (2003) Detection of lymph node micrometastases in colorectal cancer. Scand J Gastroenterol 38 (2): 125-132
37. Feezor RJ, Copeland EM 3rd, Hochwald SN (2002) Significance of micrometastases in colorectal cancer. Ann Surg Oncol 9 (10): 944-953
38. Noura S, Yamamoto H, Ohnishi T et al (2002) Comparative detection of lymph node micrometastases of stage II colorectal cancer by reverse transcriptase polymerase chain reaction and immunohistochemistry. J Clin Oncol 20 (20): 4232-4241